(BCHMF)

$74.45 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 300
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 58 595 2021
Fax: 41 58 595 2043
Address:
Hauptstrasse 144, Bubendorf, Switzerland
Fingerlickengood
Fingerlickengood Apr. 30 at 12:54 PM
$CDXS $BCHMF https://www.linkedin.com/posts/bachem_tidesusa-bachemattides-cdmo-activity-7455488682909741056-4QfL?utm_medium=ios_app&rcm=ACoAAGLfcucBavaf-gPzij2JDt92dE9y9fN8j7w&utm_source=social_share_send&utm_campaign=copy_link
1 · Reply
bstr
bstr Apr. 24 at 8:38 AM
If you missed crypto and AI, peptides is your next change to catch an insane narrative unfolding. Don't get caught up in $HIMS, rather have a look at Bachem $BCHMF (swiss listing better under $BANB). They supply to $NVO , $LLY and have around 25% of the market. Pays a dividend. Swiss. Highly profitable and decades of history. The two best things: Rarely discussed on X/Reddit and super small float available for retail (~15%). The founding family still owns 58%! The rest is locked in hands of institutions like the Norwegian Sovereign Wealth Fund. This means the stock can move up fast and on small buys.
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 17 at 8:37 PM
$CDXS $BCHMF https://www.worldpharmaceuticals.net/pressreleases/efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/ https://www.linkedin.com/feed/update/urn:li:ugcPost:7450906105779712000/?originTrackingId=LJMFT2JwRB6RZBKy0nlM4g%3D%3D
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 17 at 2:15 PM
$CDXS $NVS $BCHMF $ALNY As of this am, it looks like it is up and running! https://www.linkedin.com/company/codexis/posts/?feedView=all
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 16 at 2:13 PM
$CDXS $BCHMF $NVS https://www.linkedin.com/company/axolabs-com/posts/?feedView=all
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 11 at 8:09 PM
$CDXS $NVS $BCHMF https://www.codexis.com/blogs/how-to-scale-the-manufacturing-of-rna-therapeutics/
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 11 at 8:02 PM
$CDXS VERY INTERESTING, AxoLabs is providing a lecture about Inclisiran at TIDES on May 12th? $BCHMF $NVS https://informaconnect.com/tides/speakers/ingo-rhl-phd/
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 9 at 3:48 PM
$CDXS $ALNY $BCHMF If you haven't watched this video yet and are an investor here, or considering you should. It's very suggestive of what's upcoming in the near future in regards to AMVUTTRA (vutrisiran) with both Codexis and Bachem taking the reigns of manufacturing! https://www.bachem.com/knowledge-center/webinar-efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
1 · Reply
Fingerlickengood
Fingerlickengood Apr. 7 at 2:30 PM
$CDXS So what do we know as fact right now: (1) Codexis is involved in with $MRK on the manufacturing of enlicitide (M-0616) through a biocatalytic process to produce trans-3-hydroxy-l-proline, a critical intermediate for synthesizing the oral PCSK9 inhibitor enlicitide decanoate (MK-0616), developed by Merck. (2) Codexis and $BCHMF are involved with $ALNY through the manufacturing of Vutrisiran which is currently going through an FDA fast track for the treatment of patients with transthyretin-mediated amyloidosis with cardiomyopathy/ATTR-CM. That right there ALONE makes this worth $ $3.50+. MANY additional partnerships in the works!
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 6 at 5:34 PM
$CDXS $BCHMF https://www.bachem.com/knowledge-center/webinar-efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
0 · Reply
Latest News on BCHMF
No data available.
Fingerlickengood
Fingerlickengood Apr. 30 at 12:54 PM
$CDXS $BCHMF https://www.linkedin.com/posts/bachem_tidesusa-bachemattides-cdmo-activity-7455488682909741056-4QfL?utm_medium=ios_app&rcm=ACoAAGLfcucBavaf-gPzij2JDt92dE9y9fN8j7w&utm_source=social_share_send&utm_campaign=copy_link
1 · Reply
bstr
bstr Apr. 24 at 8:38 AM
If you missed crypto and AI, peptides is your next change to catch an insane narrative unfolding. Don't get caught up in $HIMS, rather have a look at Bachem $BCHMF (swiss listing better under $BANB). They supply to $NVO , $LLY and have around 25% of the market. Pays a dividend. Swiss. Highly profitable and decades of history. The two best things: Rarely discussed on X/Reddit and super small float available for retail (~15%). The founding family still owns 58%! The rest is locked in hands of institutions like the Norwegian Sovereign Wealth Fund. This means the stock can move up fast and on small buys.
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 17 at 8:37 PM
$CDXS $BCHMF https://www.worldpharmaceuticals.net/pressreleases/efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/ https://www.linkedin.com/feed/update/urn:li:ugcPost:7450906105779712000/?originTrackingId=LJMFT2JwRB6RZBKy0nlM4g%3D%3D
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 17 at 2:15 PM
$CDXS $NVS $BCHMF $ALNY As of this am, it looks like it is up and running! https://www.linkedin.com/company/codexis/posts/?feedView=all
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 16 at 2:13 PM
$CDXS $BCHMF $NVS https://www.linkedin.com/company/axolabs-com/posts/?feedView=all
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 11 at 8:09 PM
$CDXS $NVS $BCHMF https://www.codexis.com/blogs/how-to-scale-the-manufacturing-of-rna-therapeutics/
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 11 at 8:02 PM
$CDXS VERY INTERESTING, AxoLabs is providing a lecture about Inclisiran at TIDES on May 12th? $BCHMF $NVS https://informaconnect.com/tides/speakers/ingo-rhl-phd/
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 9 at 3:48 PM
$CDXS $ALNY $BCHMF If you haven't watched this video yet and are an investor here, or considering you should. It's very suggestive of what's upcoming in the near future in regards to AMVUTTRA (vutrisiran) with both Codexis and Bachem taking the reigns of manufacturing! https://www.bachem.com/knowledge-center/webinar-efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
1 · Reply
Fingerlickengood
Fingerlickengood Apr. 7 at 2:30 PM
$CDXS So what do we know as fact right now: (1) Codexis is involved in with $MRK on the manufacturing of enlicitide (M-0616) through a biocatalytic process to produce trans-3-hydroxy-l-proline, a critical intermediate for synthesizing the oral PCSK9 inhibitor enlicitide decanoate (MK-0616), developed by Merck. (2) Codexis and $BCHMF are involved with $ALNY through the manufacturing of Vutrisiran which is currently going through an FDA fast track for the treatment of patients with transthyretin-mediated amyloidosis with cardiomyopathy/ATTR-CM. That right there ALONE makes this worth $ $3.50+. MANY additional partnerships in the works!
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 6 at 5:34 PM
$CDXS $BCHMF https://www.bachem.com/knowledge-center/webinar-efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 6 at 5:14 PM
$BCHMF $CDXS There you go!
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 2 at 3:52 PM
$CDXS $BCHMF $ARWR https://fluidmgmt.ak-bio.com/newsroom/asahi-kasei-bioprocess-and-axolabs-announce-strategic-partnership-to-accelerate-oligonucleotide-therapeutics-development/
2 · Reply
Fingerlickengood
Fingerlickengood Mar. 26 at 3:50 PM
$CDXS $BCHMF https://www.biospace.com/fda/fdas-manufacturing-designation-could-derisk-mid-development-manufacturing-changes
1 · Reply
Fingerlickengood
Fingerlickengood Mar. 17 at 11:29 PM
$CDXS $BCHMF 17 March 2026 Bachem Reports Strong Sales Growth And Sustained High Profitability: "Commercial production will be ramped up gradually in 2026 while the second construction phase is completed. The successful ramp-up of commercial production in Building K is a key prerequisite for achieving the sales target in 2026." https://www.bachem.com/knowledge-center/bachem-reports-strong-sales-growth-and-sustained-high-profitability/ Can you say, "vutrisiran aka Amvuttra"
0 · Reply
Fingerlickengood
Fingerlickengood Mar. 14 at 8:31 PM
$CDXS $BCHMF https://www.cbsnews.com/brandstudio/codexis/
0 · Reply
Fingerlickengood
Fingerlickengood Mar. 11 at 10:14 PM
$CDXS $BCHMF Bachem earnings tomorrow...could there be a partnership annoucement coming? Why did they delay their earning announcement again! Phenominal!
0 · Reply
Fingerlickengood
Fingerlickengood Jan. 22 at 7:25 PM
$CDXS + $BCHMF + $LLYX.X https://informaconnect.com/asia-tides/agenda/2/#oligonucleotide-track_development-and-manufacture-of-oligonucleotides-via-enzymatic-ligation_3-45pm
4 · Reply
Fingerlickengood
Fingerlickengood Jan. 8 at 8:16 PM
$CDXS Something official with $BCHMF will be announced later this year in 2026! https://www.bachem.com/webinar/generic-api/efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
3 · Reply
Fingerlickengood
Fingerlickengood Jan. 6 at 3:57 PM
$CDXS $MRK $BCHMF $NVS https://themedicinemaker.com/issues/2026/articles/january/building-the-future-of-rna-manufacturing/
0 · Reply
Fingerlickengood
Fingerlickengood Dec. 19 at 11:35 PM
$CDXS "ECO Synthesis® Manufacturing Platform, a fully aqueous system that allows for massive batch sizes, feasibly scaling up to 500 kgs. $MRK $BCHMF https://www.pharmtech.com/view/how-codexis-is-transforming-rna-manufacturing"
1 · Reply
Fingerlickengood
Fingerlickengood Dec. 17 at 3:23 PM
$CDXS $BCHMF $MRK https://www.linkedin.com/posts/bachem_oligonucleotides-enzymaticligation-liquidphasesynthesis-activity-7406943770132316161-M1X1?utm_source=share&utm_medium=member_desktop&rcm=ACoAADo5XWUBEUezftCWnQa45t4uolwmtIDyz8U
0 · Reply
Fingerlickengood
Fingerlickengood Nov. 7 at 12:18 PM
$CDXS 99.9% confident soon to announce GMP partnersip with $BCHMF based on this linkedin posting. //www.linkedin.com/posts/bachem_in-our-recent-webinar-we-unpacked-the-potential-activity-7392450432830324736-j3LA?utm_source=share&utm_medium=member_desktop&rcm=ACoAADo5XWUBEUezftCWnQa45t4uolwmtIDyz8U
1 · Reply